Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials

JAMA Oncol. 2020 Sep 1;6(9):1465-1468. doi: 10.1001/jamaoncol.2020.2259.

Authors

Danielle S Bitterman¹, Kira Bona², Fran Laurie³, Pei-Chi Kao², Stephanie A Terezakis⁴, Wendy B London², Daphne A Haas-Kogan¹

Affiliations

¹ Dana-Farber Cancer Institute, Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts.
² Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Imaging and Radiation Oncology Core (IROC RI), Lincoln, Rhode Island.
⁴ Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis.

Abstract

This quality improvement study examines disparities in proton radiotherapy use in patients enrolled in Children’s Oncology Group Trials

MeSH terms

Female
Humans
Male
Neoplasms / epidemiology*
Neoplasms / psychology
Neoplasms / radiotherapy
Proton Therapy*
Racial Groups / psychology*
Racism / psychology*

Grants and funding